Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

Anavex’s precision medicine approach recognizes that Alzheimer’s pathology is heterogeneous, but autophagy dysfunction represents a causative co-factor that precedes divergent downstream ...

A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s the ...

Researchers show amyloid beta and tau compete for microtubule binding, disrupting cellular transport. This interference may trigger Alzheimer’s, shifting focus from protein buildup to intracellular ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss? That’s the potential promise of a new class of biomark ...

Alzheimer's disease is a form of progressive dementia that we've labored to figure out for decades. Scientists made some headway with the amyloid hypothesis of Alzheimer's disease, but progress is ...

Research on Alzheimer's disease is one of the hottest topics in the biological sciences today. In 1992, for instance, two Alzheimer's papers made it into the list of the top 25 cited papers of the ...

Alzheimer’s disease, or AD, is a terrible illness that is currently affecting 7.2 million adults in the United States. The Alzheimer’s Association predicts that without improved medical research and t ...

In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.